1856results about "Goggles" patented technology

The present invention provides protective eyewear for indoor and outdoor activities. In particular the present invention provides eyewear with an inner liner that protects the wearer's eyes from wind, dust, moisture, glare, allergens, and damaging ultraviolet radiation, while preventing lens fogging with a direct or indirect venting system.

A sustained-release microcapsule contains an amorphous water-soluble pharmaceutical agent having a particle size of from 1 nm-10 mu m and a polymer. The microcapsule is produced by dispersing, in an aqueous phase, a dispersion of from 0.001-90% (w / w) of an amorphous water-soluble pharmaceutical agent in a solution of a polymer having a wt. avg. molecular weight of 2,000-800,000 in an organic solvent to prepare an s / o / w emulsion and subjecting the emulsion to in-water drying.

The goggles of the invention utilize a substantially rigid frame with separate top and bottom individually rotatable elements, namely an upper browbar and a lower nosepiece, that firmly capture the lens from above and below. The lens is further secured to the frame by projections on each of the browbar and nosepiece which fit through apertures in the lens. At the top, a post which projects forwardly from the frame is received in the well of the browbar by snap-fit engagement. At the bottom, a prong on the rotatable nosepiece passes through a bottom aperture of the lens and is received in a recess of a bottom portion of the frame by snap-fit engagement. The apertures and cooperating projections are preferably located along the center of a one-piece lens. Thus, the rotatable browbar and nosepiece capture the lens top and bottom by edgewise compression and hold the lens front-to-back.

The present invention encompasses a solid dose delivery vehicle for ballistic administration of a bioactive material to subcutaneous and intradermal tissue, the delivery vehicle being sized and shaped for penetrating the epidermis. The delivery vehicle further comprises a stabilizing polyol glass loaded with the bioactive material and capable of releasing the bioactive material in situ. The present invention further includes methods of making and using the solid dose delivery vehicle of the invention.

An article of externally-worn eye wear, including, but not limited to, eyeglasses, sunglasses, goggles, and contact lenses. The eye wear includes a wavelength transmission blocker for blocking substantially all of light wavelengths throughout the blue light spectrum. The wavelength transmission blocker protects the eyes against the harmful effect of the blocked light. Also, since the eye wear is worn externally from the eye, and the user can remove the eye wear, the user can selectively block the light. As such, the eye wear can be worn to block potentially harmful light, or the eye wear can be removed if blocking the light would cause other hazards.

An apparatus and system, and methods for using such apparatus and system, is provided for preserving the eye's natural and artificial tears. The apparatus comprises two soft, pliable eyecups, which each include and curved lens and contoured frame, connected by a soft, pliable bridge. The lenses are maintained within a pliable, and contoured frame that is designed and constructed to encircle the orbital bone of the eye sockets, creating a custom fit and effective seal over each eye. Attached to each frame is a gasket that further seals the apparatus over the eyes and provides additional comfort to the wearer. A contoured strap, which is attached to each frame, maintains the position of the apparatus on the wearer.

An eyewear apparatus for treating dry eye conditions featuring a pair of curved eyecups having interior cavities for providing treatment to the eyes when worn. Each interior cavity has a sidewall surface adapted to removably engage with the perimeter edge of a moisture pad which may be mounted therein to provide moisture, aroma, or medicinal treatment to the eye. An ocular cavity formed in the moisture pads provides a separate treatment chamber to each of the two eyes of a user. Heat or cold may also be provided to the ocular chamber through temperature components which mount to the moisture pad or in a gap between the moisture pad and the front of the interior cavity.

An eyeglasses apparatus and transformation system thereof, facilitating quick and easy convertibility of the left and right traditionally folding temples into an adjustable headband; thereby making the light-weight eyeglasses much more suited to dynamic activities such as jogging, skiing, and cycling for example. The user of this novel eyeware can advantageously move between more sedentary situations, where the extreme appearance of eye-goggles would appear very out of place;—yet by manually releasing an inconspicuously integrated pair of bifurcated retention-latches located immediately aftward of both temple-hinges, the temples can be instantly detatched and readily interchanged with a headband employing similar slide-in bayonet-type retention-latches. The disclosure identifies a particularly critical human-factors problem addressed by the uniquely configured finger operated opposed latches; plus, the notion of my slim-lined detatchable-temples, enables a host of optional companion accessory temple embodiments, facilitating a miniature radio, cell-phone, or digital-camera;—conveniences for the person on the go!

A mixed micellar pharmaceutical formulation includes a micellar proteinic pharmaceutical agent, an lkali metal C8 to C22 alkyl sulphate, alkali metal salicylate, a pharmaceutically acceptable edetate and at least one absorption enhancing compounds. The absorption enhancing compounds are selected from the group consisting of lecithin, hyaluronic acid, pharmaceutically acceptable salts of hyaluronic acid, octylphenoxypolyethoxyethanol, glycolic acid, lactic acid, chamomile extract, cucumber extract, oleic acid, linolenic acid, borage oil, evening of primrose oil, trihydroxy oxo cholanylglycine, glycerin, polyglycerin, lysine, polylysine, triolein and mixtures thereof. The amount of each absorption enhancing compound is present in a concentration of from 1 to 10 wt. / wt. % of the total formulation, and the total concentration of absorption enhancing compounds are less than 50 wt. / wt. % of the formulation. Preferably, the formulation is administered, in combination with a propellant, to the buccal cavity, using a metered dose dispenser.

A water soluble, biodegradable reverse thermal gelation system comprising a mixture of at least two types of tri-block copolymer components is disclosed. The tri-block copolymer components are made of a hydrophobic biodegradable polyester A-polymer block and a hydrophilic polyethylene glycol B-polymer block. The drug release and gel matrix erosion rates of the biodegradable reverse thermal gelation system may be modulated by various parameters such as the hydrophobic / hydrophilic component contents, polymer block concentrations, molecular weights and gelation temperatures, and weight ratios of the tri-block copolymer components in the mixture.

A multi-chip package is disclosed comprising a plurality of memory chips, each of the memory chips comprising an internal circuit; and a power level detector for detecting a level of a power supply voltage to initialize the internal circuit, at a power-up. The power level detectors in the respective memory chips are configured to initialize corresponding internal circuits at different points of time.